.AstraZeneca has discussed a very early check out the efficiency of its own in-house antibody-drug c...
.After introducing a period 3 launch based upon good midstage end results, iTeos and also GSK are ac...
.The FDA ought to be even more open and also collaborative to unleash a surge in approvals of unusua...
.It is actually an uncommonly active Friday for biotech IPOs, with Zenas BioPharma, MBX as well as B...
.Atea Pharmaceuticals' antiviral has actually failed one more COVID-19 test, but the biotech still s...
.Neurocrine Biosciences' mental illness plan pivot has actually failed. The biotech was actually inc...
.Sanofi has made an overdue entrance to the radioligand event, spending one hundred million european...
.After F2G's 1st try to acquire a brand-new lesson of antifungal to market was actually derailed by ...
.Moderna has pledged to reduce R&D investing by $1.1 billion by 2027. The decision to shrink the ...
.Simply four months after Sanofi bet $80 thousand in beforehand cash on Fulcrum Rehabs' losmapimod, ...